Compare Quanta Services Inc (PWR) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quanta Services Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Quanta Services Inc trades at $700.31 (market cap $103.03B), while State Street SPDR S&P Biotech ETF trades at $153.85 (market cap $10.11B). The key difference: Quanta Services Inc is far larger — about 10.2× State Street SPDR S&P Biotech ETF's market cap, and Quanta Services Inc pays a 0.06% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quanta Services Inc for 62 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| PWR | XBI | |
|---|---|---|
Market Cap | $103.03B | $10.11B |
Volume | 977,892 | 12,903,266 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $785.24 | $169.55 |
52-Week Low | $412.21 | $104.99 |
Typical Hold Time | 62 Days | 38 Days |
Enterprise Value | $109.13B | — |
Dividend Yield | 0.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PWR trades at $705.94, up 0.69% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, reaching $28.48B in 2025, though valuation multiples like a P/E of 78.41 appear elevated. Positive sentiment is driven by a record $53B backlog and AI infrastructure demand, as highlighted in recent Zacks reports.
Outlook remains positive given earnings momentum and sector tailwinds, but high valuation and execution risks from rapid expansion warrant caution. The consensus price target of $802.08 implies upside, yet investors should monitor margin sustainability and competitive pressures in the construction and electrical services sector.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
